Acura Pharmaceuticals Inc (ACUR)

Currency in USD
0.0005
0.0000(0.00%)
Closed·
ACUR Scorecard
Full Analysis
Stock generally trades with high price volatility
ACUR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00050.0005
52 wk Range
0.00020.7532
Key Statistics
Prev. Close
0.0005
Open
0.0005
Day's Range
0.0005-0.0005
52 wk Range
0.0002-0.7532
Volume
5K
Average Volume (3m)
6.95K
1-Year Change
-97.5%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACUR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Acura Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Acura Pharmaceuticals Inc Company Profile

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

Compare ACUR to Peers and Sector

Metrics to compare
ACUR
Peers
Sector
Relationship
P/E Ratio
0.0x−2.1x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.7x2.6x
Price / LTM Sales
0.0x1.0x3.3x
Upside (Analyst Target)
0.0%40.8%42.9%
Fair Value Upside
Unlock0.0%6.2%Unlock

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ACUR Income Statement

FAQ

What Stock Exchange Does Acura Pharma Trade On?

Acura Pharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Acura Pharma?

The stock symbol for Acura Pharma is "ACUR."

What Is the Acura Pharma Market Cap?

As of today, Acura Pharma market cap is 33.25K.

What Is Acura Pharma's Earnings Per Share (TTM)?

The Acura Pharma EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is ACUR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Acura Pharma Stock Split?

Acura Pharma has split 6 times.

How Many Employees Does Acura Pharma Have?

Acura Pharma has 9 employees.

What is the current trading status of Acura Pharma (ACUR)?

As of 12 Aug 2025, Acura Pharma (ACUR) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.